3Evans J L,Goldfine I D,Maddux B A,et al.Oxidative stress and stress-activated signaling pathways:a unifying hypothesis of type 2 diabetes[J].Endocr Rev,2002,23(5):599-622. 被引量：1
4Ha H,Hwang I A,Park J H,Lee H B.Role of reactive oxygen species in the pathogenesis of diabetic nephropathy[J].Diabetes Res Clin Pract,2008,82(Suppl 1):S42-5. 被引量：1
5Fattman C L,Schaefer L M,Oury T D.Extracellular superoxide dismutase in biology and medicine[J].Free Radic Biol Med,2003,35(3),236-56. 被引量：1
6Xu G W,Yao Q H,Weng Q F,et al.Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients[J].J Pharm Biomed Anal,2004,36(1):101-4. 被引量：1
7Yu X,Kensler T.Nrf2 as a target for cancer chemoprevention[J].Mutat Res,2005,591:93-102. 被引量：1
8Thimmulappa R K,Mai K H,Srisuma S.Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray[J].Cancer Res,2002,62(18):5196-203. 被引量：1
9Agarwal A,Nick H S.Renal response to tissue injury:Lessons from heme oxygenase-1 gene ablation and expression[J].J Am Soc Nephrol,2000,11(5):965-73. 被引量：1
10Shen G,Jeong W S,Hu R,Kong A N.Regulation of Nrf2,NF-kappaB,and AP-1 signaling pathways by chemopreventive agents[J].Antioxidant Redox Signal,2005,7(11-12):1648-63. 被引量：1
